世界の結節性痒疹治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Prurigo Nodularis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4850
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、結節性痒疹治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（カプサイシンクリーム、抗ヒスタミン薬、その他）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・結節性痒疹治療の市場動向
・企業の競争状況、市場シェア
・結節性痒疹治療の種類別市場規模（カプサイシンクリーム、抗ヒスタミン薬、その他）
・結節性痒疹治療の用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）
・結節性痒疹治療の北米市場規模2016-2027（アメリカ、カナダ）
・結節性痒疹治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・結節性痒疹治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・結節性痒疹治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・結節性痒疹治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Johnson & Johnson、GlaxoSmithKline、Pfizer、Teva Pharmaceutical、Bayer）
・結論

Prurigo nodularis (PN), also known as nodular prurigo, is a skin disease characterised by pruritic (itchy) nodules which usually appear on the arms or legs.
Among products, antihistamines are foreseen to exhibit a higher CAGR in the global prurigo nodularis treatment market.

Market Analysis and Insights: Global Prurigo Nodularis Treatment Market
The global Prurigo Nodularis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prurigo Nodularis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prurigo Nodularis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prurigo Nodularis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prurigo Nodularis Treatment market.

Global Prurigo Nodularis Treatment Scope and Market Size
Prurigo Nodularis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prurigo Nodularis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Capsaicin Cream
Antihistamines
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
GlaxoSmithKline
Pfizer
Teva Pharmaceutical
Bayer

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prurigo Nodularis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Capsaicin Cream
1.2.3 Antihistamines
1.2.4 Others
1.3 Market by Application
1.3.1 Global Prurigo Nodularis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prurigo Nodularis Treatment Market Perspective (2016-2027)
2.2 Prurigo Nodularis Treatment Growth Trends by Regions
2.2.1 Prurigo Nodularis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prurigo Nodularis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Prurigo Nodularis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Prurigo Nodularis Treatment Industry Dynamic
2.3.1 Prurigo Nodularis Treatment Market Trends
2.3.2 Prurigo Nodularis Treatment Market Drivers
2.3.3 Prurigo Nodularis Treatment Market Challenges
2.3.4 Prurigo Nodularis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prurigo Nodularis Treatment Players by Revenue
3.1.1 Global Top Prurigo Nodularis Treatment Players by Revenue (2016-2021)
3.1.2 Global Prurigo Nodularis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Prurigo Nodularis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prurigo Nodularis Treatment Revenue
3.4 Global Prurigo Nodularis Treatment Market Concentration Ratio
3.4.1 Global Prurigo Nodularis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prurigo Nodularis Treatment Revenue in 2020
3.5 Prurigo Nodularis Treatment Key Players Head office and Area Served
3.6 Key Players Prurigo Nodularis Treatment Product Solution and Service
3.7 Date of Enter into Prurigo Nodularis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prurigo Nodularis Treatment Breakdown Data by Type
4.1 Global Prurigo Nodularis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Prurigo Nodularis Treatment Forecasted Market Size by Type (2022-2027)

5 Prurigo Nodularis Treatment Breakdown Data by Application
5.1 Global Prurigo Nodularis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Prurigo Nodularis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prurigo Nodularis Treatment Market Size (2016-2027)
6.2 North America Prurigo Nodularis Treatment Market Size by Type
6.2.1 North America Prurigo Nodularis Treatment Market Size by Type (2016-2021)
6.2.2 North America Prurigo Nodularis Treatment Market Size by Type (2022-2027)
6.2.3 North America Prurigo Nodularis Treatment Market Size by Type (2016-2027)
6.3 North America Prurigo Nodularis Treatment Market Size by Application
6.3.1 North America Prurigo Nodularis Treatment Market Size by Application (2016-2021)
6.3.2 North America Prurigo Nodularis Treatment Market Size by Application (2022-2027)
6.3.3 North America Prurigo Nodularis Treatment Market Size by Application (2016-2027)
6.4 North America Prurigo Nodularis Treatment Market Size by Country
6.4.1 North America Prurigo Nodularis Treatment Market Size by Country (2016-2021)
6.4.2 North America Prurigo Nodularis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Prurigo Nodularis Treatment Market Size (2016-2027)
7.2 Europe Prurigo Nodularis Treatment Market Size by Type
7.2.1 Europe Prurigo Nodularis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Prurigo Nodularis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Prurigo Nodularis Treatment Market Size by Type (2016-2027)
7.3 Europe Prurigo Nodularis Treatment Market Size by Application
7.3.1 Europe Prurigo Nodularis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Prurigo Nodularis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Prurigo Nodularis Treatment Market Size by Application (2016-2027)
7.4 Europe Prurigo Nodularis Treatment Market Size by Country
7.4.1 Europe Prurigo Nodularis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Prurigo Nodularis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prurigo Nodularis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Prurigo Nodularis Treatment Market Size by Type
8.2.1 Asia-Pacific Prurigo Nodularis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prurigo Nodularis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prurigo Nodularis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Prurigo Nodularis Treatment Market Size by Application
8.3.1 Asia-Pacific Prurigo Nodularis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prurigo Nodularis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prurigo Nodularis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Prurigo Nodularis Treatment Market Size by Region
8.4.1 Asia-Pacific Prurigo Nodularis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prurigo Nodularis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prurigo Nodularis Treatment Market Size (2016-2027)
9.2 Latin America Prurigo Nodularis Treatment Market Size by Type
9.2.1 Latin America Prurigo Nodularis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Prurigo Nodularis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Prurigo Nodularis Treatment Market Size by Type (2016-2027)
9.3 Latin America Prurigo Nodularis Treatment Market Size by Application
9.3.1 Latin America Prurigo Nodularis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Prurigo Nodularis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Prurigo Nodularis Treatment Market Size by Application (2016-2027)
9.4 Latin America Prurigo Nodularis Treatment Market Size by Country
9.4.1 Latin America Prurigo Nodularis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Prurigo Nodularis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prurigo Nodularis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Prurigo Nodularis Treatment Market Size by Type
10.2.1 Middle East & Africa Prurigo Nodularis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prurigo Nodularis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prurigo Nodularis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Prurigo Nodularis Treatment Market Size by Application
10.3.1 Middle East & Africa Prurigo Nodularis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prurigo Nodularis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prurigo Nodularis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Prurigo Nodularis Treatment Market Size by Country
10.4.1 Middle East & Africa Prurigo Nodularis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prurigo Nodularis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Prurigo Nodularis Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Prurigo Nodularis Treatment Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Prurigo Nodularis Treatment Introduction
11.2.4 GlaxoSmithKline Revenue in Prurigo Nodularis Treatment Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Prurigo Nodularis Treatment Introduction
11.3.4 Pfizer Revenue in Prurigo Nodularis Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Prurigo Nodularis Treatment Introduction
11.4.4 Teva Pharmaceutical Revenue in Prurigo Nodularis Treatment Business (2016-2021)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Prurigo Nodularis Treatment Introduction
11.5.4 Bayer Revenue in Prurigo Nodularis Treatment Business (2016-2021)
11.5.5 Bayer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Prurigo Nodularis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Capsaicin Cream
Table 3. Key Players of Antihistamines
Table 4. Key Players of Others
Table 5. Global Prurigo Nodularis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Prurigo Nodularis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Prurigo Nodularis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Prurigo Nodularis Treatment Market Share by Regions (2016-2021)
Table 9. Global Prurigo Nodularis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Prurigo Nodularis Treatment Market Share by Regions (2022-2027)
Table 11. Prurigo Nodularis Treatment Market Trends
Table 12. Prurigo Nodularis Treatment Market Drivers
Table 13. Prurigo Nodularis Treatment Market Challenges
Table 14. Prurigo Nodularis Treatment Market Restraints
Table 15. Global Prurigo Nodularis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Prurigo Nodularis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Prurigo Nodularis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prurigo Nodularis Treatment as of 2020)
Table 18. Ranking of Global Top Prurigo Nodularis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Prurigo Nodularis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Prurigo Nodularis Treatment Product Solution and Service
Table 22. Date of Enter into Prurigo Nodularis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Prurigo Nodularis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Prurigo Nodularis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Prurigo Nodularis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Prurigo Nodularis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Prurigo Nodularis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Prurigo Nodularis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Prurigo Nodularis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Prurigo Nodularis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Prurigo Nodularis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Prurigo Nodularis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Prurigo Nodularis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Prurigo Nodularis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Prurigo Nodularis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Prurigo Nodularis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Prurigo Nodularis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Prurigo Nodularis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Prurigo Nodularis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Prurigo Nodularis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Prurigo Nodularis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Prurigo Nodularis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Prurigo Nodularis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Prurigo Nodularis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Prurigo Nodularis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Prurigo Nodularis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Prurigo Nodularis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Prurigo Nodularis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Prurigo Nodularis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Prurigo Nodularis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Prurigo Nodularis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Prurigo Nodularis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Prurigo Nodularis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Prurigo Nodularis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Prurigo Nodularis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Prurigo Nodularis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Prurigo Nodularis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Prurigo Nodularis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Prurigo Nodularis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Prurigo Nodularis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Johnson & Johnson Company Details
Table 63. Johnson & Johnson Business Overview
Table 64. Johnson & Johnson Prurigo Nodularis Treatment Product
Table 65. Johnson & Johnson Revenue in Prurigo Nodularis Treatment Business (2016-2021) & (US$ Million)
Table 66. Johnson & Johnson Recent Development
Table 67. GlaxoSmithKline Company Details
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Prurigo Nodularis Treatment Product
Table 70. GlaxoSmithKline Revenue in Prurigo Nodularis Treatment Business (2016-2021) & (US$ Million)
Table 71. GlaxoSmithKline Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Prurigo Nodularis Treatment Product
Table 75. Pfizer Revenue in Prurigo Nodularis Treatment Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Teva Pharmaceutical Company Details
Table 78. Teva Pharmaceutical Business Overview
Table 79. Teva Pharmaceutical Prurigo Nodularis Treatment Product
Table 80. Teva Pharmaceutical Revenue in Prurigo Nodularis Treatment Business (2016-2021) & (US$ Million)
Table 81. Teva Pharmaceutical Recent Development
Table 82. Bayer Company Details
Table 83. Bayer Business Overview
Table 84. Bayer Prurigo Nodularis Treatment Product
Table 85. Bayer Revenue in Prurigo Nodularis Treatment Business (2016-2021) & (US$ Million)
Table 86. Bayer Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prurigo Nodularis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Capsaicin Cream Features
Figure 3. Antihistamines Features
Figure 4. Others Features
Figure 5. Global Prurigo Nodularis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Prurigo Nodularis Treatment Report Years Considered
Figure 10. Global Prurigo Nodularis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Prurigo Nodularis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Prurigo Nodularis Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Prurigo Nodularis Treatment Market Share by Regions (2022-2027)
Figure 14. Global Prurigo Nodularis Treatment Market Share by Players in 2020
Figure 15. Global Top Prurigo Nodularis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prurigo Nodularis Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Prurigo Nodularis Treatment Revenue in 2020
Figure 17. Global Prurigo Nodularis Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Prurigo Nodularis Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Prurigo Nodularis Treatment Market Share by Type (2016-2027)
Figure 21. North America Prurigo Nodularis Treatment Market Share by Application (2016-2027)
Figure 22. North America Prurigo Nodularis Treatment Market Share by Country (2016-2027)
Figure 23. United States Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Prurigo Nodularis Treatment Market Share by Type (2016-2027)
Figure 27. Europe Prurigo Nodularis Treatment Market Share by Application (2016-2027)
Figure 28. Europe Prurigo Nodularis Treatment Market Share by Country (2016-2027)
Figure 29. Germany Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Prurigo Nodularis Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Prurigo Nodularis Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Prurigo Nodularis Treatment Market Share by Region (2016-2027)
Figure 39. China Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Prurigo Nodularis Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Prurigo Nodularis Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Prurigo Nodularis Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Prurigo Nodularis Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Prurigo Nodularis Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Prurigo Nodularis Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Prurigo Nodularis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Johnson & Johnson Revenue Growth Rate in Prurigo Nodularis Treatment Business (2016-2021)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Prurigo Nodularis Treatment Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Prurigo Nodularis Treatment Business (2016-2021)
Figure 61. Teva Pharmaceutical Revenue Growth Rate in Prurigo Nodularis Treatment Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Prurigo Nodularis Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

以下、関連資料のご紹介

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界のMSD治療市場規模・現状・予測（2021年-2027年）

Global MSD Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3939 2021年4月 91Pages
QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジ...

世界の高カルシウム血症治療市場規模・現状・予測（2021年-2027年）

Global Hypercalcemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2989 2021年4月 93Pages
QYResearch社発行の本調査資料では、高カルシウム血症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビスフォスフォネート、糖質コルチコイド、カルシウム模倣薬）、用途別市場規模（軽度高カルシウム血症、中度高カルシウム血症、重度高カルシ...

世界のアフリカトリパノソーマ症治療市場規模・現状・予測（2021年-2027年）

Global African Trypanosomiasis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0157 2021年4月 95Pages
QYResearch社発行の本調査資料では、アフリカトリパノソーマ症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（MS-08、CBL-0137、AN-5568、GNF-6702、その他）、用途別市場規模（研究センター、病院、クリニック、そ...

世界の神経芽細胞腫治療市場規模・現状・予測（2021年-2027年）

Global Neuroblastoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4085 2021年4月 90Pages
QYResearch社発行の本調査資料では、神経芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ...

世界のクラッベ病治療市場規模・現状・予測（2021年-2027年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3334 2021年4月 92Pages
QYResearch社発行の本調査資料では、クラッベ病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗けいれん薬、筋弛緩薬、HSCT（造血幹細胞移植）、その他）、用途別市場規模（病院、ASC）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界のクッシング病治療市場規模・現状・予測（2021年-2027年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
世界の変形性関節症治療市場規模・現状・予測（2021年-2027年） Osteoarthritis (OA) is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The most common symptoms are joint pain and stiffness. Initially, symptoms may occur only following exercise, but over time may become constant. Other symptoms may include joint swellin…
世界の萎縮性胃炎治療市場規模・現状・予測（2021年-2027年） Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular cell and replacement by fibrous tissue, intestinal type epithelium, and pyloric type glands. It mainly associated H. Pylori bacterial infection, and autoimmunity dire…
世界のアトピー性湿疹治療市場規模・現状・予測（2021年-2027年） Atopic eczema (atopic dermatitis) is the most common form of eczema, a condition that causes the skin to become itchy, dry and cracked. Market Analysis and Insights: Global Atopic Eczema Treatment Market The global Atopic Eczema Treatment market size is projected to reach US$ XX million by 2026, fro…
世界の脂漏性皮膚炎治療市場規模・現状・予測（2021年-2027年） Seborrhoeic dermatitis is a long-term skin disorder. Seborrhoeic dermatitis symptoms include red, scaly, greasy, itchy and inflamed skin. Market Analysis and Insights: Global Seborrheic Dermatitis Treatment Market The global Seborrheic Dermatitis Treatment market size is projected to reach US$ XX mi…